Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$5.8M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$131M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Hitchcock Michael J.M. | Sep 30, 2024 | Buy | 10,000 | $10.06 | $100,000 |
| Valle Franco | Jun 11, 2024 | Buy | 12,509 | $4.4257 | $55,000 |
| A2A Pharmaceuticals, Inc. | Jun 1, 2023 | Sell | 50,000 | $34.5633 | $1.7M |
| A2A Pharmaceuticals, Inc. | May 31, 2023 | Sell | 75,000 | $33.81 | $2.5M |
| A2A Pharmaceuticals, Inc. | May 12, 2023 | Sell | 25,000 | $33.84 | $850,000 |
| A2A Pharmaceuticals, Inc. | May 9, 2023 | Sell | 150,000 | $34.5048 | $5.2M |
| A2A Pharmaceuticals, Inc. | May 8, 2023 | Sell | 100,000 | $33.9931 | $3.4M |
| A2A Pharmaceuticals, Inc. | Apr 20, 2023 | Sell | 200,000 | $29.1188 | $5.8M |
| A2A Pharmaceuticals, Inc. | Mar 31, 2023 | Sell | 200,000 | $31.25 | $6.3M |
| Cormorant Asset Management, LP | Mar 30, 2023 | Buy | 400,000 | $30 | $12M |
What's the latest insider transaction for Biomea Fusion?
The most recent insider transaction for Biomea Fusion was conducted by Hitchcock Michael J.M., who sold 10,000 shares on September 30, 2024 at a price of $10.06 per share.
Which insider bought the most BMEA stock over the last two years?
Cormorant Asset Management, LP has bought the most BMEA stock in the last 2 years, with a total value of $12M.
Which insider has sold the most BMEA stock over the last two years?
A2A Pharmaceuticals, Inc. has sold the most BMEA stock in the last 2 years, with a total value of $26M.
What is the total value of insider transactions for Biomea Fusion (BMEA) in the last 2 years?
The total value of insider transactions for Biomea Fusion in the last 2 years is negative, amounting to -$14M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Biomea Fusion's market confidence?
Over the last 2 years, insider transactions for Biomea Fusion have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
